Allos Therapeutics, Inc. (Nasdaq: ALTH), presents initial data from COMPLETE, an international registry designed to address the urgent need for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE